Jun 02, 2020 / 04:00PM GMT
Peter S. Greenleaf - Aurinia Pharmaceuticals Inc. - President, CEO & Director
Good morning and welcome to the 2020 Aurinia Pharmaceuticals Inc. Annual General and Special Meeting. The meeting will now come to order. My name is Peter Greenleaf, and I'm the President and Chief Executive Officer of the corporation. Pursuant to the bylaws of the corporation, I will be acting as the Chairman of the meeting.
As you know, we took the initiative to move to a virtual format for our Annual General Meeting this year in response to the COVID-19 global pandemic to ensure the health and safety of our shareholders, our employees and the general community.
In addition to tabling our financial statements, there are 8 motions that we will be voting on today. Once all of the motions have been voted on, we will announce our preliminary voting results, and the business of the meeting will officially come to a close.
I will ask Stephen Robertson, our Corporate Secretary of the company, to act as secretary for this meeting, and I will ask Kyle Gould of Computershare Investor Services Inc. to act
Aurinia Pharmaceuticals Inc Annual Shareholders Meeting Transcript
Jun 02, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers